METRO | METRO HEALTHCARE BERHAD
0.225 (0.0%)
T-O (am): 0.000 (08:59:00)
Last updated: 16:59
METRO Fundamental Trend
FCON: | Sharpe Ratio: | LTS:
METRO Quarter Reports
Customize
Select columns required and click "Update" to save your preferences
| Ann. Date | Qtr. Date | Q | FYE | Revenue [M] | PBT [M] | NP [M] | NPM | DPS | EPS | R. QoQ | R. YoY | E. QoQ | E. YoY | TTM EPS |
Adj. [M] |
NP [M] (adj) |
NPM (adj) |
EPS (adj) |
E. QoQ (adj) |
E. YoY (adj) |
TTM EPS (adj) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 22 Aug 25 | Q2 Jun 25 | 2 | 31 Dec 25 | 12.63 | 1.74 | 1.20 | 9.5% | 0.00 | 0.12 | 13.6% | 293.5% | ||||||||||
| 23 May 25 | Q1 Mar 25 | 1 | 31 Dec 25 | 11.12 | 0.62 | 0.31 | 2.8% | 0.00 | 0.03 | 6.3% | 163.9% | ||||||||||
| 27 Feb 25 | Q4 Dec 24 | 4 | 31 Dec 24 | 11.87 | 0.10 | -0.48 | -4.0% | 0.00 | -0.07 | 3.4% | 131.9% | ||||||||||
| 22 Nov 24 | Q3 Sep 24 | 3 | 31 Dec 24 | 12.29 | 1.92 | 1.50 | 12.2% | 0.00 | 0.24 |
METRO Historical Dividends
METRO Financial Ratios
| EPS | 0.26 sen |
| Trailing PE (Sector Median: 28.5) | 86.9 |
| PEG | 0.87 |
| Altman Z | 1.5 |
| Beaver | 0.112 |
| Current Ratio | 9.08 |
| Debt-Equity (DE) Ratio | 0.28 |
| FCF Yield | 0.76 % |
| Revenue QoQ | 13.57 % |
| Revenue YoY | 0% |
| Profit QoQ | 293.46 % |
| Profit YoY | 0 % |
| Profit Margin (Sector Median: 7.2) | 5.28 % |
| ROE (ROIC: 3.46) | 3.46 % |
| Dividend Per Share (DPS) | 0.0 sen |
| Dividend Yield (DY) | 0.0 % |
METRO Adjusted Financial Ratios
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
| EPS | |
| Trailing PE (Sector Median: 28.5) | |
| Profit QoQ | |
| Profit YoY | |
| Profit Margin (Sector Median: 7.2) | |
| ROE (ROIC: 4.33) | |
| Altman Z |
METRO Fair Value
Weighted Average Fair Value:
| Discounted Cash Flow (DCF) 5% Growth | |
| Discounted Cash Flow (DCF) 10% Growth | |
| Relative Valuation | |
| Average Analysts FV based on 2 rating(s) |
| Graham Formula | |
| Graham Number | |
| Net Tangible Asset (NTA) | 0.07 | Consistent QR FV |
Advanced Calculators
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
| Forward PE FV Calculator | |
| Latest Profit (adjusted) [M] | 1.28 |
| Expected Profit (Next QR) [M] | |
| Expected Profit (After QR above) [M] | |
| Expected Profit (After QR above) [M] | |
| Estimated Fair Value |
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 0 |
| Expected Revenue (M) | 0 |
| Expected Growth (%) | 0 |
METRO Directors Share Purchases (Beta)
No transaction in the last 2 months.
METRO Summary
Market Cap: 220 M.
Market Cap Class: Small caps
Number of Shares: 978 M.
Adjusted Float: 0%.
Metro Healthcare Berhad is primarily focused on providing obstetrics and gynecological (O&G) healthcare services, with a specialization in fertility treatments. The company has strategically shifted its focus to enhance its core offerings in O&G healthcare, which include comprehensive fertility services and general obstetrics and gynecological care. To complement these services, Metro Healthcare also offers pediatric services; however, it has discontinued dental and traditional Chinese medicine fertility services as of 2022 and 2023, respectively. This realignment reflects the company’s commitment to strengthening its position within the O&G healthcare sector. Metro Healthcare was incorporated in 2010 and headquartered in Klang, Selangor, Malaysia.
Sectors: Healthcare, Health Care Providers, Penny Stocks
Code: 0329
Website: https://www.metro.com.my/
Related Links: Bursa | Annual Report | Announcement
Warrant Info:
No warrants listed
METRO Top Shareholdings
| Shareholder | % | Value (M) |
|---|---|---|
| Dr Tay Swi Peng @ Tee Swi Peng | 43.48% | 95.77 |
| Encik Sheikh Mohd Nasarudin | 5.11% | 11.25 |
| Lim Wai Khong | 0.79% | 1.74 |
| Cik Rose Zilawati Binti Mohamed Arifin | 0.01% | 0.02 |
| Dr Yee Meng Kheong | 0.01% | 0.02 |
| Chua Leng Leek | 0.01% | 0.02 |
| Seah Cheong Wei | 0.0% | 0.01 |
Frequently Asked Questions
METRO HEALTHCARE BERHAD Latest News
IPO Insights
Metro Healthcare Berhad
Metro Healthcare Berhad is primarily focused on providing obstetrics and gynecological (O&G) healthcare services, with a specialization in fertility treatments. The company has strategically shifted its focus to enhance its core offerings in O&G healthcare, which include comprehensive fertility services and general obstetrics and gynecological care. To complement these services, Metro Healthcare also offers pediatric services; however, it has discontinued dental and traditional Chinese medicine fertility services as of 2022 and 2023, respectively. This realignment reflects the company’s commitment to strengthening its position within the O&G healthcare sector. Metro Healthcare was incorporated in 2010 and headquartered in Klang, Selangor, Malaysia.
IPO Details
Utilisation of Proceeds
| Purpose | Amount (RM'000) | % | |
|---|---|---|---|
| Expansion | Expansion of existing O&G business | 25,000 | 63.85 |
| Working capital | Working capital | 7,329 | 18.72 |
| Others | Refurbishment and upgrading of the business premises | 3,000 | 7.66 |
| Listing expenses | Estimated listing expenses | 3,827 | 9.77 |
| Total | 39,156 | 100 | |
Utilisation of Proceeds
SWOT Analysis
Sorry, this feature only available for iSaham Pro